Barely Significant
← all excerpts

Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.

BMC Musculoskelet Disord · 2013 · PMC3840772 · PMID 24156640

1
hedged sentence
closest p
boldest claim

The sentences

nominally significantno p-value reported
Averaged over Days 4 to 7, both etoricoxib dose groups (120 mg, 90 mg) showed nominally significant greater reduction from baseline as compared with placebo on Pain Intensity with Knee Flexion.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.